News & Events about West Pharmaceutical Services Inc.
Azimuth Capital Investment Management LLC raised its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST Get Rating) by 35.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 35,046 shares of ...
Czech National Bank raised its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST Get Rating) by 0.7% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 8,666 shares of the medical instruments suppliers stock ...
West Announces Second-Quarter 2023 Dividend West Announces Second-Quarter 2023 Dividend PR Newswire EXTON, Pa., March 3, 2023 EXTON, Pa., March 3, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration...
Stock Options Channel
1 year ago
Investors in West Pharmaceutical Services, Inc. (WST) saw new options begin trading today, for the January 2024 expiration...
West Pharmaceutical Services, Inc. (NYSE:WST Get Rating) CEO Eric Mark Green sold 44,000 shares of the companys stock in a transaction on Monday, December 5th. The stock was sold at an average price of $238.99, for a total value of $10,515,560.00. Following the transaction, the chief executive ...